Cognition Therapeutics Data Shows Retinal Cell Health Impact
Clinical Trial Vanguard
By Jon Napitupulu
May 12, 2025
Cognition Therapeutics Data Shows Retinal Cell Health Impact Read More »
Zervimesine Robustly Slows Geographic Atrophy Lesion Growth in Latest Phase 2 MAGNIFY Data
Neurology Live
By Marco Meglio
May 10, 2025
Hamby ME, Lizama BN, Reaver A, et al. Sigma-2 Receptor Modulation Promotes Retinal Pigment Epithelial Cell Survival Following Chronic 7-Ketocholesterol Exposure. Poster presented at ARVO 2025; Salt Lake City, UT
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics
Ophthalmology Times
By Emily Kaiser Maharjan
May 8, 2025
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics Read More »
Lizama BN, Reaver A, Cho E, et al. Sigma-2 Receptor Modulators Alter Low-density Lipoprotein Receptor-mediated Lipid Trafficking in Retinal Pigmented Epithelial Cells. Poster presented at 2024 Keystone Conference on Dry Age-related Macular Degeneration; Pacific Grove, CA.
Reaver A, Lizama BN, Caggiano AO, Hamby ME. Differentiated retinal pigment epithelial cells as a model for uncovering sigma-2 receptor functions and novel therapeutics for dry AMD. Poster presented at 2024 Association for Research in Vision & Ophthalmology.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
